MED vs. GLD
MED (Medifast, Inc.) is a stock, while GLD (SPDR Gold Shares) is Gold fund tracking the LBMA Gold Price PM. Over the past 10 years, MED returned -7.29%/yr vs 12.15%/yr for GLD. At a 0.04 correlation, their price movements are largely independent.
Performance
MED vs. GLD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MED achieves a 11.33% return, which is significantly higher than GLD's -2.47% return. Over the past 10 years, MED has underperformed GLD with an annualized return of -7.29%, while GLD has yielded a comparatively higher 12.15% annualized return.
MED
- 1D
- -0.25%
- 1M
- -4.73%
- YTD
- 11.33%
- 6M
- -3.80%
- 1Y
- -8.40%
- 3Y*
- -46.74%
- 5Y*
- -45.89%
- 10Y*
- -7.29%
GLD
- 1D
- 0.06%
- 1M
- -7.37%
- YTD
- -2.47%
- 6M
- -2.25%
- 1Y
- 22.21%
- 3Y*
- 28.89%
- 5Y*
- 17.08%
- 10Y*
- 12.15%
MED vs. GLD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MED Medifast, Inc. | 11.33% | -39.39% | -73.79% | -38.34% | -42.31% | 9.36% | 86.18% | -9.73% | 82.11% | 72.33% |
GLD SPDR Gold Shares | -2.47% | 63.68% | 26.66% | 12.69% | -0.77% | -4.15% | 24.81% | 17.86% | -1.94% | 12.81% |
Correlation
The correlation between MED and GLD is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.03 |
Correlation (All Time) Calculated using the full available price history since Nov 18, 2004 | 0.04 |
The correlation between MED and GLD shifts across timeframes, from -0.07 (1 year) to 0.04 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MED vs. GLD — Risk / Return Rank
MED
GLD
MED vs. GLD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and SPDR Gold Shares (GLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MED | GLD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.11 | ||
| Sortino ratioReturn per unit of downside risk | -1.30 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.18 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | -0.26 | 0.98 | -1.24 |
| Martin ratioReturn relative to average drawdown | -0.44 | 2.81 | -3.25 |
Loading charts...
Drawdowns
MED vs. GLD - Drawdown Comparison
The maximum MED drawdown since its inception was -98.40%, which is greater than GLD's maximum drawdown of -45.56%. Use the drawdown chart below to compare losses from any high point for MED and GLD.
Loading charts...
Drawdown Indicators
| MED | GLD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.40% | -45.56% | -52.84% |
Max Drawdown (1Y)Largest decline over 1 year | -37.39% | -24.46% | -12.93% |
Max Drawdown (3Y)Largest decline over 3 years | -90.91% | -24.46% | -66.45% |
Max Drawdown (5Y)Largest decline over 5 years | -96.29% | -24.46% | -71.83% |
Max Drawdown (10Y)Largest decline over 10 years | -96.76% | -24.46% | -72.30% |
Current DrawdownCurrent decline from peak | -95.96% | -22.05% | -73.91% |
Average DrawdownAverage peak-to-trough decline | -50.84% | -16.16% | -34.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.83% | 8.49% | +13.34% |
Volatility
MED vs. GLD - Volatility Comparison
Medifast, Inc. (MED) has a higher volatility of 8.94% compared to SPDR Gold Shares (GLD) at 7.79%. This indicates that MED's price experiences larger fluctuations and is considered to be riskier than GLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MED | GLD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.94% | 7.79% | +1.15% |
Volatility (6M)Calculated over the trailing 6-month period | 31.69% | 24.10% | +7.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.90% | 27.37% | +14.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.25% | 18.22% | +27.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.68% | 16.08% | +31.60% |
Dividends
MED vs. GLD - Dividend Comparison
Neither MED nor GLD has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GLD SPDR Gold Shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MED Medifast, Inc. | 0.00% | 0.00% | 0.00% | 7.36% | 5.69% | 2.71% | 2.30% | 3.08% | 1.75% | 2.06% | 2.57% | 0.82% |
Frequently Asked Questions
MED and GLD have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MED has higher volatility (8.94%) compared to GLD (7.79%). In terms of maximum drawdown, MED dropped -98.40% vs GLD's -45.56%.
GLD currently has the higher Sharpe Ratio (0.87 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MED and GLD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer